Menu
Not yet recruiting NCT06925256

Considering Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography?

No phase Interventional Neuropathic Peripheral Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: nerve conduction study.
Who it may be relevant to
Registry conditions: Neuropathic Peripheral Pain. Basic parameters: 20 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Considerin Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography?

Overview

So far, apart from a limited number of case reports and small-scale studies, the frequency and severity of this complication have not been objectively evaluated using electromyography (EMG). In this study, presence, severity, and extent of nerve injury (one of the potential complications following the transradial approach (TRA)) were evaluated by EMG studies in patients managed at Bursa City Hospital.

Detailed description

Evaluation of peripheral nerve injury after transradial angiography with nerve conduction studies.

Interventions

  • Diagnostic test nerve conduction study
    median ulnar and radial motor- sensory nerve conduction studies will be performed.

Primary outcome measures

  • Nerve conduction studies (NCS) [Time frame: 1 day]

Eligibility criteria

Inclusion criteria

20-60 years old patiens who applied trans angiograhy were included to study

Exclusion criteria

  • Having cognitive disorders
  • Patients who have story of cardiac pace / ICD,
  • History of polyneuropathy,
  • Previous nerve damages,
  • Deformities on arm,
  • Plexopathy,
  • Radiculopathy,
  • Spinal surgery.
  • Having medical treatment for any kind of neuropathy
  • Having Cognitive disorders

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Screening

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06925256 · 2025-PMR-1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗